Similar articles

• [Association of renal lesions with Walker 256 adenocarcinoma. Influence of sex and age].

  Dinh BL, Brassard A, Legault A, Katiyar VN. Dinh BL, et al. Bull Cancer. 1971 Oct-Dec;58(4):467-84. Bull Cancer. 1971. PMID: 4949253 French. No abstract available.
• [Animal experiments research with tumor-transferrin complex].

  Scheiffarth F, Götz H, Herbst HW. Scheiffarth F, et al. Med Exp Int J Exp Med. 1969;19(3):170-82. Med Exp Int J Exp Med. 1969. PMID: 4985675 German. No abstract available.
• Feto-tumor serum antigens. Serologic studies with the Walker 256 tumor-rat model.

  Harshman S. Harshman S. J Natl Cancer Inst. 1971 Oct;47(4):871-80. J Natl Cancer Inst. 1971. PMID: 4999592 No abstract available.
• [Further studies on problems of immunological growth arrest of malignant tumors].

  Götz H, Flügel H. Götz H, et al. Med Exp Int J Exp Med. 1969;19(3):149-60. Med Exp Int J Exp Med. 1969. PMID: 4985674 German. No abstract available.
• Urinary cyclic AMP and bone histology in Walker carcinosarcoma: evidence of parathyroid hormone-like activity.

  Schmidt-Gayk H, Löhrke H, Fischkal A, Goerttler K, Hofmann F. Schmidt-Gayk H, et al. Eur J Cancer (1965). 1979 Oct;15(10):1211-8. doi: 10.1016/0014-2964(79)90246-9. Eur J Cancer (1965). 1979. PMID: 230054 No abstract available.